Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxy/TUDCA in Cardiac Amyloidosis
NCT03481972Phase 3Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Apr 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxycycline, tauroursodeoxycholic acid in transthyretin amyloid cardiomyopathy (ATTR-CM), sponsored by IRCCS San Matteo Foundation. Started Apr 2018; status: completed.
02
Drugs
doxycyclinetauroursodeoxycholic acid
03
Conditions
transthyretin amyloid cardiomyopathy (ATTR-CM)
Beyond the preview
Go deeper on NCT03481972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03481972.